Gentian Diagnostics: Key information relating to the proposed cash dividend

Moss, 12 February 2026

The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per share, based on the company's financial statements for the financial year 2025, to the General Meeting.

Dividend amount: 0.60 per share Announced currency: Norwegian krone (NOK) Last day including right: 5 May 2026 Ex-date: 6 May 2026 Record date: 7 May 2026 Payment date: from 18 May 2026 Date of approval: 5 May 2026

For further information, please contact:

Njaal Kind, CFO njaal.kind@gentian.no +47 919 06 525 (mobile)

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.